{
    "code": "01003442",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01003442",
    "time": "2019-12-20 03:52:10",
    "許可證字號": "衛署藥製字第003442號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/08\/29",
    "發證日期": "62\/08\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100344200",
    "中文品名": "“榮民”治鼻敏錠4毫克",
    "英文品名": "CHLORPHENIRAMINE MALEATE TABLETS &quot;VPP&quot;",
    "適應症": "緩解過敏性鼻炎、枯草熱所引起之相關症狀（流鼻水、打噴嚏、眼睛及喉部搔癢）及過敏所引起之搔癢、皮膚癢疹。預防或緩解暈車、暈船、暈機所引起之頭暈、噁心、嘔吐、頭痛。",
    "劑型": "110錠劑",
    "包裝": "1000錠以下塑膠瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "623202D135  榮民製藥股份有限公司",
        "申請商地址": "桃園市中壢區中山東路３段４４７號",
        "主製造廠": ""
    },
    "CCC號列": "30049099101 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "",
            "含量": "4.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "009",
        "標記二": "榮民1"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "01003442.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01003442&Seq=012&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥製字第003442號 Chlorpheniramine Maleate Tablets 4mg-20150917-104-09-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01003442&Seq=006&Type=9"
        },
        {
            "title": "010034420002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01003442&Seq=001&Type=8"
        }
    ]
}